BEIJING (Reuters) -A potential COVID-19 vaccine from China’s Clover Biopharmaceuticals was 67% effective against COVID-19 of any degree of severity […]
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok